Hyperion Therapeutics Completes Phase 2 Data Analysis and ...
... for its Phase 2 clinical trial designed to evaluate the safety, tolerability and ammonia scavenging effects of HPN-100 versus BUPHENYL(R) (sodium phenylbutyrate), the current standard of care in patients with urea cycle disorders. ...
Our experience with our hospice
... and she is still under the care of her team of Stanford doctors (pulmonologist, neurologist, nutrition, gastrointestinal) -- we actually went through the sodium phenylbutyrate clinical trial at Stanford while on hospice. ...
Hyperion Therapeutics Completes Phase 2 Data Analysis And ...
Hyperion Therapeutics, Inc. reported completion of data analysis for its Phase 2 clinical trial designed to evaluate the safety, tolerability and ammonia scavenging effects of HPN-100 versus BUPHENYL(R) (sodium phenylbutyrate), ...
Medicis Declares Cash Dividend
... BUPHENYL(R) (sodium phenylbutyrate) Tablets and Powder and AMMONUL(R) (sodium phenylacetate and sodium benzoate) Injection 10%/10%. For more information about Medicis, please visit the Company's website at www.Medicis.com. ...
Medicis Announces Intent to Restate Financial Statements. News.
... and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, BUPHENYL(R) (sodium phenylbutyrate) Tablets and Powder and AMMONUL(R) (sodium phenylacetate and sodium benzoate) Injection 10%/10%, drug Products indicated in the ...
Good News and Bad News
We will be watching closely to see if there is any loss of the movement that has seemed to increase this summer while she was on the sodium phenylbutyrate compound. We are all really tired after the long drive and deflated after the ...
No change = good news
Unfortunately, as a result of this "adverse change", we had to stop giving her the clinical trial medication, sodium phenylbutyrate. Assuming Gwendolyn's condition doesn't change, on Monday we'll be heading up to Stanford to meet with ...
Alzforum: News
... that the HDAC inhibitor sodium 4-phenylbutyrate rescues cognitive deficits in Tg2576 mice, a widely used AD model that overexpresses mutant human amyloid precursor protein (APP) and develops memory impairment by nine to 10 months. ...
sodium phenylbutyrate information - side effects, uses and benefits
sodium phenyl butyrate may have to be taken for life unless you receive a liver transplant. may cause drowsiness, fatigue, fainting, or light-headedness. use caution while driving or performing other tasks that require alertness, ...
